Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients with Refractory Ascites

por Arase, Yoshitaka, Kagawa, Tatehiro, Tsuruya, Kota, Sato, Hirohiko, Teramura, Erika, Anzai, Kazuya, Hirose, Shunji, Deguchi, Ryuzo, Shiraishi, Koichi, Mine, Tetsuya
Publicado 2018

Efficacy and Safety of 3‐Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases

por Arase, Yoshitaka, Tsuruya, Kota, Hirose, Shunji, Ogiwara, Naoki, Yokota, Masashi, Anzai, Kazuya, Deguchi, Ryuzo, Shiraishi, Koichi, Shirai, Takayuki, Kagawa, Tatehiro
Publicado 2019

Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Mass and Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

por Arase, Yoshitaka, Shiraishi, Koichi, Anzai, Kazuya, Sato, Hirohiko, Teramura, Erika, Tsuruya, Kota, Hirose, Shunji, Deguchi, Ryuzo, Toyoda, Masao, Mine, Tetsuya, Kagawa, Tatehiro
Publicado 2019

Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy

por Deguchi, Ryuzo, Nakaminami, Hidemasa, Rimbara, Emiko, Noguchi, Norihisa, Sasatsu, Masanori, Suzuki, Takayoshi, Matsushima, Masashi, Koike, Jun, Igarashi, Muneki, Ozawa, Hideki, Fukuda, Ryuki, Takagi, Atsushi
Publicado 2012